Mucosal vaccines and technology
- PMID: 30963541
- PMCID: PMC6468177
- DOI: 10.1111/cei.13285
Mucosal vaccines and technology
Abstract
There is an urgent and unmet need to develop effective vaccines to reduce the global burden of infectious disease in both animals and humans, and in particular for the majority of pathogens that infect via mucosal sites. Here we summarise the impediments to developing mucosal vaccines and review the new and emerging technologies aimed at overcoming the lack of effective vaccine delivery systems that is the major obstacle to developing new mucosal vaccines.
Keywords: bacterial; mucosal; vaccines; viral.
© 2019 The Authors. Clinical & Experimental Immunology published by John Wiley & Sons Ltd on behalf of British Society for Immunology.
Conflict of interest statement
The authors report no conflicts of interest.
References
-
- Vaccines and vaccination . National Office of Animal Health Available at: https://www.noah.co.uk/briefingdocument/antibiotic-resistance-2/ (accessed 26 November 2018).
-
- Grace DMF, Ochungo P, Kruska R et al Mapping of poverty and likely zoonoses hotspots. Zoonoses Project 4. Nairobi, Kenya: International Livestock Research Institute (ILRI), 2012.
-
- Hoft DF, Brusic V, Sakala IG. Optimizing vaccine development. Cell Microbiol 2011; 13:934–42. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
- BB/M011216/1/BB_/Biotechnology and Biological Sciences Research Council/United Kingdom
- BB/J004529/1/BB_/Biotechnology and Biological Sciences Research Council/United Kingdom
- BB/R012490/1/BB_/Biotechnology and Biological Sciences Research Council/United Kingdom
- BBS/E/F000PR10355/BB_/Biotechnology and Biological Sciences Research Council/United Kingdom
- BBS/E/F/000PR10355/BB_/Biotechnology and Biological Sciences Research Council/United Kingdom
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
